Skip to content
Biodatica
Start free

Cho Pharma Inc.

Taipei

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: Digital Health Solutions for Patients With Type 2 Diabetes

5w agoTrial registeredJun 11, 2026Source filing (opens the source filing in a new tab)

Momentum

90no change

Momentum 90 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    May 28, 2026

    Diabetes Mellitus Type 2 · ENROLLING_BY_INVITATION · sponsor: Chang Gung Memorial Hospital · Digital Health Solutions for Patients With Type 2 Diabetes

    ClinicalTrials.gov · NCT07642830 (opens the source filing in a new tab)

  2. Trial

    PHASE1/PHASE2 registered

    Dec 1, 2025

    Advanced Solid Tumors · NOT_YET_RECRUITING · sponsor: Cho Pharma Inc. · Study of CHO-A04 in Advanced Solid Tumors

    ClinicalTrials.gov · NCT07049458 (opens the source filing in a new tab)

  3. Trial

    NA registered

    Apr 10, 2025

    Aging, Skin Health · RECRUITING · sponsor: China Medical University Hospital · The Effects of Cosmetic Acupuncture

    ClinicalTrials.gov · NCT06952959 (opens the source filing in a new tab)

  4. Trial

    NA registered

    Feb 1, 2024

    Diabetic Patients,Self-Care,Artificial Intelligence-Based,Self-Efficacy, Type 2 Diabetes Mellitus (T2DM) · COMPLETED · sponsor: Chia-Tzu Line · Diabetic Patients,Self-Efficacy,Self-Care Behaviors,Artificial Intelligence-Based

    ClinicalTrials.gov · NCT06985680 (opens the source filing in a new tab)

  5. Trial

    NA registered

    Apr 18, 2023

    Stroke · COMPLETED · sponsor: CHIA-HUEI LIN, PhD · Vibration Training for Patients With Chronic Stroke

    ClinicalTrials.gov · NCT07554794 (opens the source filing in a new tab)

  6. Trial

    NA registered

    Jul 1, 2022

    Advanced Care Planning · RECRUITING · sponsor: The University of Hong Kong · Implementing a Nurse-led Advance Care Planning (ACP) Intervention in Residential Care Homes

    ClinicalTrials.gov · NCT06238063 (opens the source filing in a new tab)

  7. Trial

    NA registered

    Jan 17, 2022

    Vibration; Exposure, Rehabilitation · COMPLETED · sponsor: Tri-Service General Hospital (TSGH) · Effectiveness of Vibration Training on Functional Recovery and Mood State Among Patients With Acute Stroke

    ClinicalTrials.gov · NCT05462028 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources